- Home
- DXCM vs GEHC Comparison
DXCM vs GEHC Comparison
Compare DXCM & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- GEHC
- Stock Information
- Founded
- DXCM 1999
- GEHC 1892
- Country
- DXCM United States
- GEHC United States
- Employees
- DXCM N/A
- GEHC N/A
- Industry
- DXCM Medical/Dental Instruments
- GEHC Computer Software: Prepackaged Software
- Sector
- DXCM Health Care
- GEHC Technology
- Exchange
- DXCM Nasdaq
- GEHC Nasdaq
- Market Cap
- DXCM 34.1B
- GEHC 34.8B
- IPO Year
- DXCM 2005
- GEHC N/A
- Fundamental
- Price
- DXCM $83.52
- GEHC $75.13
- Analyst Decision
- DXCM Strong Buy
- GEHC Strong Buy
- Analyst Count
- DXCM 20
- GEHC 10
- Target Price
- DXCM $98.50
- GEHC $89.10
- AVG Volume (30 Days)
- DXCM 3.8M
- GEHC 3.8M
- Earning Date
- DXCM 07-30-2025
- GEHC 07-30-2025
- Dividend Yield
- DXCM N/A
- GEHC 0.18%
- EPS Growth
- DXCM N/A
- GEHC 38.77
- EPS
- DXCM 1.33
- GEHC 4.76
- Revenue
- DXCM $4,148,000,000.00
- GEHC $19,799,000,000.00
- Revenue This Year
- DXCM $16.74
- GEHC $5.19
- Revenue Next Year
- DXCM $15.29
- GEHC $4.71
- P/E Ratio
- DXCM $62.58
- GEHC $15.78
- Revenue Growth
- DXCM 9.11
- GEHC 1.56
- 52 Week Low
- DXCM $57.52
- GEHC $57.65
- 52 Week High
- DXCM $117.19
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- DXCM 49.26
- GEHC 56.35
- Support Level
- DXCM $82.73
- GEHC $74.38
- Resistance Level
- DXCM $85.92
- GEHC $77.32
- Average True Range (ATR)
- DXCM 2.63
- GEHC 1.63
- MACD
- DXCM -0.09
- GEHC 0.11
- Stochastic Oscillator
- DXCM 54.33
- GEHC 72.03
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).